Pulmozyme (Genentech, Inc.)
Welcome to the PulseAid listing for the Pulmozyme drug offered from Genentech, Inc.. This Decreased Respiratory Secretion Viscosity [PE],Deoxyribonuclease I [Chemical/Ingredient],Recombinant Human Deoxyribonuclease 1 [EPC],Recombinant Proteins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Genentech, Inc. |
NON-PROPRIETARY NAME: | dornase alfa |
SUBSTANCE NAME: | DORNASE ALFA |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Decreased Respiratory Secretion Viscosity [PE],Deoxyribonuclease I [Chemical/Ingredient],Recombinant Human Deoxyribonuclease 1 [EPC],Recombinant Proteins [Chemical/Ingredient] |
ROUTE: | RESPIRATORY (INHALATION) |
DOSAGE FORM: | SOLUTION |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 1993-12-30 |
END MARKETING DATE: | 0000-00-00 |
Pulmozyme HUMAN PRESCRIPTION DRUG Details:
Item Description | Pulmozyme from Genentech, Inc. |
LABELER NAME: | Genentech, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1(mg/mL) |
START MARKETING DATE: | 1993-12-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 50242-100_e93b9176-2d17-4a2a-9b09-65ff6b6e21c6 |
PRODUCT NDC: | 50242-100 |
APPLICATION NUMBER: | BLA103532 |
Other DORNASE ALFA Pharmaceutical Manufacturers / Labelers: